Skip Navigation
  Print Page

Consultation on the Inclusion of Adolescents in HIV Biomedical Prevention Clinical Trials

Skip sharing on social media links
Share this:

June 17-19, 2009


Pediatric, Adolescent, and Maternal AIDS (PAMA) Branch, Center for Research for Mothers and Children (CRMC), NICHD; Division of AIDS, National Institute of Allergy and Infectious Diseases; NIH Office of AIDS Research; National Institute of Mental Health; National Institute on Drug Abuse; and Forum for Collaborative HIV Research


Washington, DC
Purpose: This meeting will provide a forum for examining the scientific, logistical, ethical, and regulatory issues relevant to the inclusion of adolescents in HIV biomedical prevention trials and will discuss the broader inclusion of adolescents as clinical trial participants.


Dr. Bill Kapogiannis, PAMA Branch, CRMC, NICHD
Tel: (301) 402-0698

Last Updated Date: 11/30/2012
Last Reviewed Date: 11/30/2012
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology